Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1500
-0.0050 (-3.23%)
Aug 5, 2026, 1:04 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 19.27 million as of August 5, 2026. Its market cap has decreased by -77.61% in one year.
Market Cap
19.27M
Enterprise Value
14.23M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 19.27M, an increase of 1.28%. That is a compound annual growth rate of 0.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 19.27M | -49.15% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imugene | 34.93M |
| Algorae Pharmaceuticals | 24.31M |
| Noxopharm | 24.27M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| Neurotech International | 22.40M |
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| EZZ Life Science Holdings | 21.89M |